The Patent Finder
US

Inhibitors of Bruton's Tyrosine Kinase

US 8,883,435 Grace period ended
OverviewFamilyAssignmentsSources & methods

Term ends Sep 25, 2029 · Low confidence

Grace period ended Nov 11, 2026 · no payment on record as of the Nov 17, 2026 fee file · lapse expected

Filed Jun 8, 2010 as application 12/594,805 · Granted Nov 11, 2014
Base term plus 1002 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2006 2029
Clock starts
Dec 28, 2006
Term ends
Sep 25, 2029
Granted
Nov 11, 2014
base term patent term adjustment fee events Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,002
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
76
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 1002 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: Low: the grace period for its third maintenance fee ended Nov 11, 2026 with no payment on record. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 28, 2006, when application 11/617,645, the earliest non-provisional in its chain, was filed (this one was filed Jun 8, 2010)Dec 28, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1002 days, USPTO patent term adjustment recordSep 25, 2029High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee eventsRead from the payments on the fee record: none for this window, and its grace period has ended. No fee event states a lapse, and USPTO's status still reads "Patented Case".grace period ended Nov 11, 2026Low confidence
Computed term endThe steps above, in orderSep 25, 2029Low confidence

Partial family

US 7,514,444In force
no later than Dec 2026
no later than Dec 2026
US 7,732,454In force
Apr 2027
Apr 2027
US 7,825,118In force
Jan 2028
Jan 2028
Application PCT/US2008/058528PCT application
no patent term
no patent term
US 8,088,781In force
no later than Dec 2027
no later than Dec 2027
US 8,501,751In force
Dec 2026
Dec 2026
US 8,008,309In force
Nov 2027
Nov 2027
Application 12/499,008Abandoned
not computed
not computed
8 of 76 applications in this family shown, earliest filings first. Partial: 6 of the 76 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 13, 2010
Reel 24676, frame 157
Honigberg, Lee; Verner, Erik J.; Buggy, Joseph J.; Loury, David J.; Chen, WeiPharmacyclics, Inc.Assignment of Assignor's Interest
Jul 16, 2015
Reel 36126, frame 377
Oxford Amherst CorporationPharmacyclics, Inc.Merger
Jul 16, 2015
Reel 36126, frame 398
Pharmacyclics, Inc.; Oxford Amherst LLCPharmacyclics LLCMerger and Change of Name
May 17, 2016
Reel 38722, frame 776
Oxford Amherst Corporation; Pharmacyclics, Inc.Pharmacyclics, Inc.Corrective Assignment to Correct the Conveying Party Data Previously Recorded on Reel 036126 Frame 0377. Assignor(S) Hereby Confirms the Merger.
May 17, 2016
Reel 38722, frame 849
Pharmacyclics, Inc.; Oxford Amherst LLCPharmacyclics LLCCorrective Assignment to Correct the Conveying Party Data Previously Recorded on Reel 036126 Frame 0398. Assignor(S) Hereby Confirms the Merger and Change of Name.

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited